Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.

Name: Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series.
Author: Naqash, Abdul Rafeh

Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. — المؤلف: Naqash, Abdul Rafeh — Journal for immunotherapy of cancer 20200401

المؤلف: Naqash, Abdul Rafeh
النشر: Journal for immunotherapy of cancer 20200401
الوصف: 4 p.
الموضوعات: Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Azetidines؛ Exanthema؛ Female؛ Humans؛ Immunotherapy؛ MAP Kinase Kinase Kinases